Crestovo LLC   Report issue

For profit Phase 2
Founded: Cambridge MA United States (2014)
Status: Acquired by Finch Research and Development LLC. (2017)

Organization Overview

First Clinical Trial
2017
NCT03110133
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (1)

microbiota (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Clostridium Infections (Phase 2)

Communicable Diseases (Phase 2)

Infections (Phase 2)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 1